Introduction {#Sec1}
============

Porcine circovirus type 2 (PCV2) is an immunosuppressive virus in pigs. It is a small, nonenveloped, single-stranded DNA virus that belongs to the circoviridae family \[[@CR1]\]. The virus genome contains two major open reading frames (ORFs), ORF1 and ORF2. ORF1 encodes the replication proteins which are involved in virus replication, and ORF2 encodes the capsid (Cap) protein \[[@CR2], [@CR3]\]. PCV2 has been identified as the etiologic agent of the Postweaning Multisystemic Wasting Syndrome (PMWS) \[[@CR4], [@CR5]\] that is widely spread in swine farms and represents one of several porcine circovirus associated diseases (PCVAD). PCV2 infection usually accompanies lymphocyte or monocyte depletion and thus further results in immune suppression in the disease \[[@CR6], [@CR7]\]. The immunosuppressive disease mainly presents as PMWS, which caused a great economic loss worldwide \[[@CR8], [@CR9]\]. However, the immunosuppressive and pathogenic mechanisms have remained unclear in PCV2-infected pigs.

Proteomics analysis is a powerful technology used in a myriad of studies, including those focused on infectious diseases \[[@CR10], [@CR11]\]. Isobaric tags for relative and absolute quantification (iTRAQ) combined with multidimensional liquid chromatography (LC) and tandem MS analysis are emerging as a powerful methodology in the search for disease-specific targets \[[@CR12], [@CR13]\]. The iTRAQ reagent labels the primary amines on the peptides and thus can theoretically allow the tagging of most tryptic peptides. The multiplexing ability afforded by the iTRAQ reagents, which are available in four to eight different tags, suited the design of our present study.

Although PCVAD causes substantial economic losses, PCV2 pathogenesis is not fully understood. For elucidation of the interaction between host and PCV2, proteome analysis has been utilized for host cellular responses to virus infection. Ramírez-Boo \[[@CR14]\] used two proteomics strategies, 2-DE and 1-DE, followed by (16)O/(18)O peptide labeling, identification, and quantification via MS, leading to the detection of more than 100 differentially expressed proteins during PCV2 infection in an in vivo environment. Additionally, Zhang et al. \[[@CR15].\] identified 34 host-encoded proteins that were altered in PCV2-infected PK-15 cells using two-dimensional gel electrophoresis (2-DE) coupled with MALDI-TOF/TOF, while Fan and colleagues \[[@CR16]\] detected 163 proteins that were significantly affected in PCV2-infected PK-15 cells with the SILAC-based approach. The group of Cheng \[[@CR17]\] examined PCV2-infected porcine alveolar macrophages (PAMs) using 2-DE, followed by MALDI-TOF/TOF, and identified 21 host-encoded proteins modified by the virus. A quantitative proteomics approach by our group revealed significant alterations in 145 cellular proteins in PCV2 infected PAMs at different time periods post-infection \[[@CR18]\].

In the current study, we described quantitative proteomic analysis of a highly permissive PK-15 cell line (cloned by our laboratory) infected with PCV2 using isobaric tags for relative and absolute quantification, combined with multidimensional liquid chromatography and tandem MS analysis. Overall, we detected 196 proteins showing significant alterations in expression at different time periods post-infection. These proteins may serve as potential biomarkers to establish the interactions between PK-15 and PCV2, and provide novel insights into the mechanisms of disease onset.

Materials and methods {#Sec2}
=====================

Reagents {#Sec3}
--------

Tris-base, SDS, and the 2-D Quantification Kit were purchased from GE Healthcare (Piscataway, NJ, USA). Octane and sequencing grade-modified trypsin were obtained from Sigma-Aldrich (St. Louis, MO). The iTRAQ Reagent Kit was acquired from Applied Biosystems (Foster City, CA). Acetonitrile (ACN) was purchased from Fisher Scientific (Pittsburgh, PA), formic acid (FA) from TEDIA (Fairfield, OH), and trichloroacetic acid (TCA), KH~2~PO~4~, methanol, acetone, HCl, and KCl from Sinopharm Chemical Reagent Co., Ltd. (Shanghai, China). All buffers were prepared with Milli-Q water (Millipore; Billerica, MA).

Cell culture and virus infection {#Sec4}
--------------------------------

Porcine circovirus type 2 strain, WG09 (GenBank accession no. GQ845027), was isolated from an intensive pig farm in Shanghai, China, in 2009. The virus stock was a fourth-passage cell culture prepared in PK-15 cells with a titer of 10^6.0^ TCID~50~/mL. PK-15 cells were grown in Dulbecco's Modified Eagle's Medium supplemented with 10 % fetal bovine serum (GIBCO, Invitrogen Corporation, CA). Cells were seeded in 25-cm^2^ culture flasks (Costar, Corning Incorporated, NY) until 75 % confluence. Next, cells were inoculated with PCV2 WG09 strain at 1 MOI and collected at 12, 24, 48, and 96 h post-inoculation (hpi), respectively. The amount of fetal bovine serum in medium was decreased to 2 %. Uninfected cells served as the mock infection group (Fig. [1](#Fig1){ref-type="fig"}). Viral propagation was confirmed via the indirect immunofluorescence assay and Western blot using a monoclonal antibody against PCV2 Cap protein (made in our laboratory).Fig. 1Strategy for isobaric tags for relative and absolute quantification (iTRAQ)-coupled two-dimensional liquid chromatography--tandem mass spectrometry (2D LC--MS/MS) analysis of PK-15 cells infected with PCV2

Protein isolation, digestion, and labeling with iTRAQ reagents {#Sec5}
--------------------------------------------------------------

After culture supernatant was being removed, cells were collected using a cell scraper after the addition of 300 μL lysis buffer (7 M urea, 2 M thiourea, 2 % (w/v) CHAPS) containing a complete protease inhibitor cocktail to the flask. Cells were lysed by sonication, the soluble protein fraction harvested by centrifugation at 15,000 × g for 40 min at 4 °C, and the pellet discarded. The protein concentration in the supernatant was determined using the 2-D Quant Kit (GE Healthcare, Piscataway, NJ). Protein (100 μg) from PK-15 cells was precipitated with acetone overnight at -20 °C and dissolved using iTRAQ dissolution buffer. After reduction and alkylation, protein solutions were digested overnight at 37 °C with sequence grade-modified trypsin (Promega) and labeled with iTRAQ tags, as described in the iTRAQ protocol (Applied Biosystems). Labeled digests were mixed and dried using a rotary vacuum concentrator (Christ RVC 2-25; Osterode am Harz, Germany). Two independent biological replicates were prepared and analyzed using iTRAQ-based LC--MS/MS.

Off-line 2D LC--MS/MS {#Sec6}
---------------------

The combined peptide mixtures were fractionated via strong cation exchange (SCX) chromatography on a 20AD high-performance liquid chromatography (HPLC) system (Shimadzu; Kyoto, Japan) using a polysulfoethyl column (2.1 × 100 mm, 5 µm, 200 Å, Poly LC, Columbia, MD). Peptides were eluted with a linear gradient of 0--500 mM KCl (10 mM KH~2~PO~4~ in 25 % v/v acetonitrile, pH 2.6) for 60 min at a flow rate of 200 µL/min. In total, twenty fractions were collected.

Each fraction was dried, dissolved in 0.1 % FA (formic acid) aqueous solution, and analyzed on a QSTAR XL system (Applied Biosystems, China) interfaced with a 20AD HPLC system (Shimadzu, Kyoto, Japan). Peptides were separated on a reverse-phase Zorbax 300SB-C18 column (75 × 150 mm, 3 µm, 100 Å, Microm, Auburn, CA). The mobile phase was composed of 0.5 % formic acid in water (A) and acetonitrile (B). The flow rate was 400 nL/min with a gradient from 5 % to 45 % B over 70 min and 90 % B over 10 min. MS data were acquired automatically using Analyst QS 1.0 software Service Pack 8 (ABI/MDS SCIEX, Concord, Canada). Survey scans were acquired from 400 to 1800, with up to 4 precursors selected for MS/MS from m/z 100 to 2000. Curtain gas was set at 10, nitrogen was used as the collision gas, and the ionization tip voltage was 4000 V.

Data analysis {#Sec7}
-------------

Relative quantification and protein identification were performed with ProteinPilot^TM^ software (version 3.0, revision 114732, Applied Biosystems) using the Paragon^TM^ algorithm as the search engine. Each MS/MS spectrum was searched against a database of Sus scrofa protein sequences (NCBI nr, released March 2008, downloaded from [ftp.ncbi.nih.gov/genomes/Sus_scrofa/protein/](http://ftp.ncbi.nih.gov/genomes/Sus_scrofa/protein/)). The search parameters allowed for cysteine modification by methyl methanethiosulfonate, and biological modifications were programmed in the algorithm (i.e., amidation, phosphorylation, and semitryptic fragments). All identified proteins required ≥95 % confidence, and the protein confidence threshold cutoff was set to 1.3 (unused) with at least more than one peptide above the 95 % confidence level. The true value for the average ratio was expressed as an error factor (EF = 10 (95 % confidence interval)) and calculated according to the reports. EF \<2 was set for satisfactory quantification quality. To designate significant changes in protein expression, fold-changes \>1.25 or \<0.75 were set as cutoff values. To decrease artificial error, the bias correction option was executed. In addition, one-way analysis of variance (ANOVA) and LSD analysis (SPSS 18.0) were used to determine whether the protein was significantly regulated over time. Differences were considered statistically significant for *P* values \<0.05.

Bioinformatics {#Sec8}
--------------

Proteins that met the criteria for differential expression were compared with hierarchical cluster analysis using Cluster 3.0 program \[[@CR19]\]. Data were displayed using Java Tree View \[[@CR20]\]. The molecular functions and subcellular localizations of the unique proteins identified were classified using Protein Center software (DAVID Functional Annotation Tools) \[[@CR21], [@CR22]\]. The main annotation types were obtained from the gene ontology consortium Web site (<http://david.abcc.ncifcrf.gov/>). The protein--protein interaction network was analyzed via STRING software (<http://string.embl.de/>) \[[@CR23]\].

Immunofluorescence assay (IFA) {#Sec9}
------------------------------

PCV2 infected cells were washed with PBS, fixed with cold acetone/methanol (1/1 v/v) for 20 min at −20 °C, and allowed to air-dry. Fixed cells were incubated with pig anti-PCV2 polyclonal antiserum (VMRD, USA) at 37 °C for 1 h, washed three times with PBST (0.05 % Tween-20 in PBS, pH 7.4), and further incubated with staphylococcal protein A (SPA) conjugated to FITC (Boshide, Wuhan, China) at 37 °C for 1 h in the dark. After three washes with PBST, infected cells were quantified using Zeiss LSM510 laser confocal microscopy.

Western blot {#Sec10}
------------

Samples of PCV2-infected and uninfected PK-15 cells were lysed at 12, 24, 48, and 96 hpi (hours post-infection), and the protein concentrations determined with the Pierce BCA Protein Assay Kit (Thermo Scientific, Product No. 23227, USA). Equivalent amounts of cell lysate proteins were subjected to 12 % SDS-PAGE and transferred to 0.22 μm nitrocellulose membranes (Hybond-C extra, Amersham Biosciences). After blotting, membranes were incubated at 37 °C for 60 min, respectively, with mouse monoclonal antibodies (mAbs) to actin (Abcam, Cambridge, UK), vimentin (Santa Cruz Biotechnology, CA), Ras-related protein Rab-11A (Santa Cruz Biotechnology, CA), Hsp90 (Abcam, Cambridge, UK), PCV2 Cap protein (made in our laboratory), or rabbit polyclonal antibody to AnnexinI (Santa Cruz Biotechnology, CA). After washing three times with 0.05 % PBST, membranes were incubated at 37 °C for 60 min with horseradish peroxidase-conjugated goat anti-mouse IgG (Boshide, Wuhan, China) or goat anti-rabbit IgG (Boshide, Wuhan, China). Detection was performed using chemiluminescence luminol reagents (SuperSignalWest PicoTrial Kit, Pierce). Protein spot levels were determined using ImageJ quantification software.

Results {#Sec11}
=======

Confirmation of PCV2 propagation in PK-15 via IFA {#Sec12}
-------------------------------------------------

Since PCV2 does not induce a typical cytopathic effect (CPE) in PK-15 cells, viral infection was confirmed by detection of PCV2 antigen using IFA at 12, 24, 48, and 96 hpi. The results clearly revealed green fluorescence in PCV2-infected PK-15 cells, which was absent in mock-infected cells. Fluorescence microscopy observations indicated that PCV2 titers increase during the first 24 h of infection, and 70--80 % of cells treated with PCV2 are infected at 96 hpi (Fig. [2](#Fig2){ref-type="fig"}).Fig. 2Detection of PCV2 in PK-15 cells with IFA. Cells inoculated with the PCV2 WG09 strain at 1 MOI and mock-infected cells were collected at 12, 24, 48, and 96 hpi, respectively. After fixing with cold acetone/methanol, cells were incubated with swine serum antibody to PCV2 and subsequently with FITC-labeled SPA (1:50). After washing, cells were examined using fluorescence microscopy (Zeiss LSM510)

Protein profile with iTRAQ-coupled 2D LC--MS/MS analysis {#Sec13}
--------------------------------------------------------

Protein extracts were prepared separately from PCV2-infected PK-15 cells at 12, 24, 48, and 96 hpi and virus-free PK-15 cells at the same time points as the mock control group. Overall, 711 proteins were detected using iTRAQ-coupled 2D LC--MS/MS analysis. Among these, 196 proteins displayed significantly altered expression post-infection. As shown in Fig. [3](#Fig3){ref-type="fig"} and Table [1](#Tab1){ref-type="table"}, significantly altered proteins were divided into eight clusters: (1) up-regulated only, (2) down-regulated only, (3) up-down regulated, (4) down-up regulated, (5) up-down-up regulated, (6) down-up-down regulated, (7) up-down-up-down regulated, and (8) down-up-down-up regulated.Fig. 3Hierarchical cluster analysis for proteins revealed significant alterations in expression levels at different time-courses post-infection. Protein expression is shown using a pseudocolor scale (from −3 to 3), with*red* indicating high expression and*green* signifying low expression (Color figure online) Table 1Statistically significant differentially expressed proteins identified by iTRAQ analysis of PK-15 cells infected with PCV2AccessionProtein nameRatio*P* value% Cov\
(95%)Peptides (95 %)Function12 hpi24 hpi36 hpi48 hpi**Cluster 1: up-regulation (63)**gi\|345441750Heat shock 70 kDa protein 80.981.03**1.562.96**4.58E−845.0543Repressor of transcriptional activationgi\|346986428Heat shock 90kD protein 10.881.111.18**2.13**3.59E−732.7331Stress responsegi\|35057965778--kDa glucose-regulated protein**1.561.461.34**1.081.79E−537.0331Facilitate the assembly of multimeric proteingi\|358009193Prolyl 4-hydroxylase beta polypeptide1.171.111.07**1.64**6.74E−637.4028Cell redox homeostasisgi\|335282386Elongation factor 21.010.981.22**2.51**4.58E−820.5116Translational elongationgi\|335293906Annexin A50.991.18**1.56**1.146.01E−742.3720Calcium ion bindinggi\|35981134760-kDa heat shock protein1.08**1.361.531.66**5.28E−723.7319Chaperone-mediated protein complex assemblygi\|350578005Ezrin0.860.81**1.321.87**3.51E−821.2114Cytoskeletal anchoring at plasma membranegi\|473575Lactate dehydrogenase-B0.83**1.331.661.36**1.48E−726.0510Cellular carbohydrate metabolic processgi\|223019599Eukaryotic translation elongation factor 11.001.16**1.421.72**2.11E−721.0017Translation elongation factor activitygi\|81174748Beta 5-tubulin0.791.08**1.721.58**5.91E−824.3216Structural constituent of cytoskeletongi\|5403631940S Ribosomal protein S171.000.87**3.25**0.991.19E−917.046rRNA processinggi\|350586583Serine/arginine-rich splicing factor 3**2.29**0.78**1.31**1.071.13E−817.683mRNA splicing, via spliceosomegi\|75074817Peroxiredoxin-60.771.11**1.39**1.214.51E−741.0718Redox regulation of the cellgi\|56748897Heat shock 70 kDa protein 1B**1.37**1.170.79**1.34**4.11E−732.7623Stress responsegi\|387912908Calreticulin0.81**1.321.38**1.244.68E−717.518Calcium ion bindinggi\|311252547T-complex protein 1 subunit delta0.94**1.261.331.58**4.30E−712.807ATP bindinggi\|51702768Peptidyl-prolyl cis--trans isomerase A1.251.00**1.631.26**4.58E−738.4110PPIases accelerate the folding of proteinsgi\|35058302214-3-3 protein zeta/delta0.79**1.321.532.21**1.70E−838.3713Cellular membrane organizationgi\|194038728Pyruvate kinase isozymes M1/M20.781.07**1.711.71**4.32E−848.2139Pyruvate kinase activitygi\|350579323Retinal dehydrogenase 10.850.90**1.601.63**6.21E−815.565Convert/oxidize retinaldehyde to retinoic acidgi\|83854099Ribosomal phosphoprotein large PO subunit**1.36**1.10**1.741.42**4.34E−721.707Structural constituent of ribosomegi\|194044922ADP/ATP translocase 2**1.72**1.200.781.209.49E−820.477Adenine transmembrane transporter activitygi\|343478174T-complex protein 1 subunit alpha0.79**1.46**1.20**1.39**2.54E−713.498ATP bindinggi\|281427370T-complex protein 1 subunit eta0.881.181.08**1.33**1.63E−69.395Binding of sperm to zona pellucidagi\|194044484Eukaryotic translation initiation factor 2 subunit 21.050.89**3.401.27**1.09E−923.725Eukaryotic translation initiation factor 2 complexgi\|349501107Ribosomal protein, large, P2**1.49**1.14**1.39**0.771.96E−760.006Protein kinase activitygi\|335285943Eukaryotic translation initiation factor 5A-1**1.49**0.92**1.46**1.073.33E−740.918Positive regulation of translational elongationgi\|374637318Heart fatty acid-binding protein1.17**2.401.431.31**2.14E−831.585Fatty acid metabolic processgi\|347582591Cytoskeleton-associated protein 4**1.961.321.38**0.865.03E−813.855High-affinity epithelial cell surface receptor for APFgi\|350592730Heterogeneous nuclear ribonucleoprotein F0.911.19**1.60**1.012.41E−718.368mRNA processinggi\|33528011360S ribosomal protein L4**1.38**0.791.12**4.29**3.10E−105.393Translational elongationgi\|389618965U2 small nuclear RNA auxiliary factor 20.97**1.26**0.88**1.53**2.74E−73.402Nucleotide bindinggi\|346644746Calmodulin 1**1.29**1.24**4.331.42**4.02E−1034.9011Calcium ion bindinggi\|311273095ATP binding cassette sub-family B member 60.860.95**1.491.37**2.27E−72.092Cadmium ion transmembrane transportgi\|54039746Tropomyosin alpha-4 chain**1.50**1.151.100.946.70E−718.556Muscle filament slidinggi\|350583632Calponin-3**1.37**1.220.90**1.56**3.44E−716.724Actomyosin structure organizationgi\|319401915Rho GDP-dissociation inhibitor 10.781.06**1.611.71**5.35E−829.907Rho protein signal transductiongi\|11550282840S ribosomal protein S30.831.10**1.461.61**1.34E−720.165DNA-(apurinic or apyrimidinic site) lyase activitygi\|350584132Proliferation-associated protein 2G40.870.85**2.191.79**1.01E−819.574ERBB3-regulated signal transduction pathwaygi\|346986388Profilin-10.881.030.90**1.82**5.23E−852.149Actin cytoskeleton organizationgi\|47523692Thioredoxin**1.45**0.97**1.57**0.951.95E−729.528Possesses a dithiol-reducing activitygi\|194036918Thiosulfate sulfurtransferase**2.25**0.92**1.29**1.151.77E−824.093Sulfur amino acid catabolic processgi\|350529387Basic transcription factor 3**1.46**1.17**1.284.09**5.44E−1024.075Transcription regulatory region DNA bindinggi\|347658971ATP synthase, H + transporting, mitochondrial Fo complex0.791.15**1.54**0.831.42E−733.544Mitochondrial ATP synthesis coupled proton transportgi\|346227212Ribosomal protein L30.891.141.13**1.87**6.42E−88.694Structural constituent of ribosomegi\|178056236RNA-binding protein 4B0.880.880.82**1.47**2.36E−77.523Nucleotide bindinggi\|5403937140S ribosomal protein S180.89**1.261.691.87**5.53E−821.053rRNA bindinggi\|87047646nm23-H2, nucleoside diphosphate kinase B0.99**1.981.491.32**7.18E−824.343GTP biosynthetic processgi\|21254962540S ribosomal protein S3a0.88**1.75**1.250.866.87E−87.952Ribonucleoprotein complexgi\|21398306760S ribosomal protein L261.241.030.86**1.96**3.79E−817.243Ribosomal large subunit biogenesisgi\|97190495Protein S100-A6**2.15**0.941.201.032.16E−816.672Signal transductiongi\|54037165Guanine nucleotide-binding protein subunit beta-20.88**1.45**1.151.106.42E−77.892G-protein coupled receptor signaling pathwaygi\|335306870Protein S100-A2**1.27**1.171.911.101.09E−716.492Endothelial cell migrationgi\|349585075Small acidic protein1.130.79**1.721.56**6.59E−821.557Regulation of gene expression, epigeneticgi\|350595172UPF0562 protein C7orf55 homolog**1.94**1.03**1.91**0.831.83E−88.084Belongs to the UPF0562 familygi\|16679606160S ribosomal protein L51.061.00**1.541.74**1.20E−76.402Ribosomal large subunit biogenesisgi\|350580630Far upstream element-binding protein 21.070.85**1.61**0.911.45E−75.764mRNA processinggi\|170997360S ribosomal protein L10a**1.63**1.03**1.431.43**5.18E−713.333RNA bindinggi\|75073672Calcium/calmodulin-dependent protein kinase type II1.061.10**1.772.65**1.52E−95.812Calcium ion transportgi\|350596533Copper transport protein ATOX1**1.33**0.78**1.961.31**3.83E−831.822Response to oxidative stressgi\|178056781Histone H2A.Z0.85**1.411.541.64**1.34E−731.256Nucleosome assemblygi\|158517860Thymosin beta-10**1.431.271.29**0.991.80E−650.005Actin cytoskeleton organization**Cluster 2: down-regulation (49)**gi\|311273021Fibronectin isoform 2**0.700.65**1.100.851.24E−613.2030Matrix organization of cartilagegi\|47523618Citrate synthase0.89**0.66**1.220.867.18E−77.763ATP catabolic processgi\|311267276Keratin type I cytoskeletal 19**0.580.68**0.791.001.16E−656.1927Organization of myofibersgi\|227430407keratin, type II cytoskeletal 8**0.600.30**0.851.111.44E−733.5421Cell morphogenesis involved in differentiationgi\|347300243Glutamate dehydrogenase 1**0.43**0.941.030.983.42E−724.0114Cellular amino acid metabolic processgi\|157279735Succinate dehydrogenase \[ubiquinone\] iron--sulfur subunit**0.590.34**1.041.001.62E−76.072Electron transportgi\|55983054Proteasome 26S subunit non-ATPase 41.21**0.740.580.31**1.02E−711.142mRNA metabolic processgi\|350594261NAD(P) transhydrogenase**0.27**0.950.830.882.19E−72.192Reactive oxygen species metabolic processgi\|343887420Transcription elongation factor A protein 11.14**0.65**1.08**0.65**4.11E−74.003C2H2 zinc finger domain bindinggi\|5739517Macrophage migration inhibitory factor1.13**0.55**0.90**0.65**4.51E−716.224Pro-inflammatory cytokinegi\|219522018Na(+)/H(+) exchange regulatory cofactor NHE-RF10.99**0.65**0.84**0.63**2.46E−66.852Wnt receptor signaling pathwaygi\|346986432ras homolog gene family, member A**0.690.65**1.050.791.98E−612.953Rho protein signal transductiongi\|350594505Annexin A6**0.44**0.750.871.074.30E−73.793Regulate the release of Ca^2+^ from intracellular storesgi\|57527987Moesin0.93**0.580.66**0.803.63E−620.8013Structural constituent of cytoskeletongi\|335284397Major vault protein isoform 1**0.640.38**0.760.861.12E−618.5615Protein transportgi\|335305558Heterogeneous nuclear ribonucleoproteins A2/B1 isoform 11.091.160.98**0.59**4.97E−743.9116pre-mRNA intronic bindinggi\|393714792Sodium/potassium-transporting ATPase subunit alpha-1**0.65**1.001.18**0.54**2.62E−717.4516Sodium/potassium transportgi\|311261216c-1-tetrahydrofolate synthase**0.540.680.530.51**5.65E−510.378Formate-tetrahydrofolate ligase activitygi\|335306989ATP-dependent RNA helicase A**0.45**0.890.86**0.70**1.26E−−65.996Putative ATP-dependent RNA helicasegi\|335299026Microtubule-associated protein 41.11**0.640.42**0.922.43E−76.575Promotes microtubule assemblygi\|350582932Annexin A13**0.600.490.60**1.004.82E−719.636Calcium ion bindinggi\|50403675Vinculin**0.650.47**1.100.972.99E−76.436Cell--matrix adhesion and cell--cell adhesiongi\|350535040Eukaryotic translation initiation factor 4 gamma 10.82**0.65**0.79**0.35**9.76E−74.136Regulation of translational initiationgi\|329663948ras GTPase-activating protein-binding protein 10.960.960.86**0.42**4.37E−715.277ATP-dependent DNA helicase activitygi\|178056550D-3-phosphoglycerate dehydrogenase**0.65**1.060.890.962.23E−69.764Amino acid biosynthesisgi\|311254317Cingulin**0.390.680.570.68**5.91E−63.184Cell junctiongi\|61216107Adenosylhomocysteinase**0.57**1.200.770.944.35E−711.345S-adenosylhomocysteine catabolic processgi\|347300176Peroxiredoxin-2**0.590.650.71**0.953.34E−618.695Involved in redox regulation of the cellgi\|311264042Hypoxia up-regulated protein 11.081.14**0.53**1.073.15E−74.815A molecular chaperone and participate in protein foldinggi\|194041525Dihydropyrimidinase-related protein 2**0.26**0.94**0.56**0.792.76E−77.243Axon guidancegi\|172072661tRNA-splicing ligase RtcB homolog1.091.10**0.660.50**1.00E−67.333tRNA splicing, via endonucleolytic cleavage and ligationgi\|347300323Thioredoxin-dependent peroxide reductase1.06**0.47**1.251.141.40E−717.624Involved in redox regulation of the cellgi\|194037005Ribonuclease UK1141.09**0.260.330.73**9.86E−838.694Nucleic acid phosphodiester bond hydrolysisgi\|350594033UDP-glucuronosyltransferase 1-10 isoform 2**0.54**0.830.751.135.82E−76.603Glucuronosyltransferase activitygi\|75039721Unconventional myosin-VI**0.640.580.570.74**5.54E−54.234Actin-based motor molecules with ATPase activitygi\|350595577Spermine synthase0.89**0.64**0.931.161.01E−69.903Spermine biosynthetic processgi\|7939586Dihydrolipoamide succinyltransferase**0.72**1.05**0.65**0.911.89E−64.612Cellular nitrogen compound metabolic processgi\|335284690Periplakin**0.25**1.241.160.955.06E−81.713Structural constituent of cytoskeletongi\|350585766Chloride intracellular channel protein 4**0.630.70**0.861.111.01E−625.195Branching morphogenesis of an epithelial tubegi\|335286747Hepatoma-derived growth factor**0.53**1.100.750.925.95E−720.583Acts as a transcriptional repressorgi\|273463176Cell division cycle 2 variant 10.79**0.660.620.27**8.53E−711.453Regulation of transcription, DNA-dependentgi\|311272155Activated RNA polymerase II transcriptional coactivator p150.98**0.54**1.10**0.65**4.19E−725.984Transcription, DNA-dependentgi\|94421332Putative aldo--keto reductase family 1 member C4**0.45**0.900.971.182.19E−78.702Oxido reductase activitygi\|311250313Histidyl-tRNA synthetase**0.59**0.751.07**0.60**8.26E−73.932tRNA aminoacylation for protein translationgi\|5403912360S ribosomal protein L220.881.150.94**0.43**2.47E−718.752Translationgi\|347300276poly(rC)-binding protein 21.030.770.94**0.67**2.97E−68.784Immunitygi\|335300686Carbonyl reductase \[NADPH\] 1**0.640.64**1.090.996.87E−711.033Carbonyl reductase (NADPH) activitygi\|194595733Clathrin light chain (CLTA) protein1.25**0.55**0.870.913.09E−733.547Cellular membrane organizationgi\|340007404Alpha-actinin-10.970.990.91**0.54**1.04E−612.2910Actin cross-link formation**Cluster 3: up-down regulation (22)**gi\|51592135Cofilin-1**1.580.55**1.001.223.39E−843.9811Regulates actin cytoskeleton dynamicsgi\|90200404Triosephosphate isomerase 1**1.260.56**0.860.843.02E−717.345Triosephosphate isomerase activitygi\|350584416Parathymosin**1.29**0.91**0.65**0.954.36E−722.553Mediate immune functiongi\|335309827Nuclear autoantigenic sperm protein**2.072.27**0.96**0.69**5.38E−97.714Required for DNA replicationgi\|335284315RNA-binding protein FUS isoform 2**1.27**0.95**0.470.68**1.45E−74.442mRNA splicing, via spliceosomegi\|350579350Stomatin-like protein 20.87**1.43**1.09**0.43**6.82E−87.933T cell receptor signaling pathwaygi\|350594172Brain acid soluble protein 1**1.450.580.24**0.902.97E−832.025Glomerular visceral epithelial cell differentiationgi\|335295652Laminin subunit beta-1**1.64**0.89**0.67**0.851.75E−53.474Cell migrationgi\|346644699Protein SET**1.36**0.93**2.030.46**1.05E−815.163Involved in apoptosis, transcription, nucleosome assembly and histone chaperoninggi\|345199274Glutaredoxin 3**1.33**0.82**2.380.65**5.65E−914.374Protein disulfide oxidoreductase activitygi\|35059132026S proteasome non-ATPase regulatory subunit 61.25**2.331.690.63**7.88E−97.354Transcription coactivator activitygi\|162951821Heterogeneous nuclear ribonucleoprotein A/B1.24**1.330.67**1.242.47E−713.255Binds single-stranded RNAgi\|346716324Myosin regulatory light chain 2 protein isoform 2**1.540.69**1.030.861.14E−717.443Cardiac myofibril assemblygi\|311249564Heterogeneous nuclear ribonucleoprotein H**1.85**1.201.12**0.10**7.61E−915.817Regulation of RNA splicinggi\|311247963Apoptosis inhibitor 5 isoform 11.04**1.630.180.53**1.31E−84.202Apoptosisgi\|350591535Hypothetical protein LOC100522278**1.46**0.790.88**0.67**1.31E−77.922Nonegi\|83921635FKBP1A**1.47**0.77**0.62**1.091.03E−725.003Beta-amyloid formationgi\|75069665ADP-ribosylation factor-like protein 30.75**1.741.280.69**3.50E−814.292Cilium morphogenesisgi\|48675927Tropomyosin alpha-3 chain**2.190.70**0.901.041.03E−843.5521Binds to actin filamentsgi\|350595802SH3 domain-binding glutamic acid-rich-like protein1.041.05**1.380.48**1.07E−718.972SH3/SH2 adaptor activitygi\|194034833Microfibrillar-associated protein 10.91**1.410.53**0.791.12E−77.062Extracellular matrix organizationgi\|31125094328 kDa heat- and acid-stable phosphoprotein1.18**1.291.460.62**1.18E−719.782Enhances PDGFA-stimulated cell growth in fibroblasts**Cluster 4: down-up regulation (43)**gi\|408360214Vimentin0.97**0.570.551.58**3.85E−870.17106Class-III intermediate filamentsgi\|28948618Annexin A1**0.34**1.22**1.642.91**1.59E−943.9326Calcium/phospholipid-binding proteingi\|335291884Histone H2B type 1**0.69**1.21**1.41**1.001.29E−757.9423Nucleosome assemblygi\|350578257Heterogeneous nuclear ribonucleoprotein Q isoform 10.751.25**0.693.70**5.06E−1017.179mRNA processinggi\|335284210HSP 27**0.74**0.99**1.491.26**1.94E−728.2512Stress resistance and actin organizationgi\|350580027Elongation factor 1-gamma**0.53**0.851.14**1.28**1.70E−717.857Translation elongation factor activitygi\|194043605GTP-binding nuclear protein Ran**0.591.31**0.99**2.19**9.64E−919.915GTP-binding protein involved in nucleocytoplasmic transportgi\|9857227Ribophorin I**0.390.741.49**0.884.69E−86.253Glycotransferase activitygi\|311245228Serpin B5**0.44**1.06**1.60**0.954.06E−810.673Tumor suppressorgi\|350591497ras-related protein Rab-7a1.13**0.651.41**1.132.09E−720.093Key regulator in endolysosomal traffickinggi\|255683404Isocitrate dehydrogenase**0.481.33**1.240.999.83E−87.523NADPH regenerationgi\|343887407Thiopurine S-methyltransferase**0.680.561.721.60**1.56E−822.044Nucleobase-containing compound metabolic processgi\|335281298Tubulin beta-2C chain0.87**0.651.43**0.791.51E−724.2717Structural constituent of cytoskeletongi\|8745552Voltage-dependent anion channel 1**0.621.69**1.211.085.55E−825.446Voltage-gated anion channel activitygi\|304365428Protein disulfide-isomerase A31.11**0.541.53**1.117.62E−830.3018Signal transductiongi\|8745554Voltage-dependent anion channel 2**0.720.651.271.42**9.28E−821.437Voltage-gated anion channel activitygi\|194034450Nidogen-2**0.301.69**1.181.031.91E−87.668Cell--matrix adhesiongi\|75056558Ras-related protein Rab-11A**0.410.692.131.69**4.84E−915.744Melanosome transportgi\|346986294Uncharacterized protein LOC100155717 isoform 2**0.460.641.451.87**1.04E−819.724Peroxiredoxin (PRX)-like 2 familygi\|311245734Hypothetical protein LOC1000380231.00**0.69**1.18**2.17**6.97E−914.064mTOR signaling pathwaygi\|47522630Aspartate aminotransferase**0.61**1.211.06**1.85**3.01E−811.636Aspartate biosynthetic processgi\|346227216Ribosomal protein L150.95**0.741.392.09**2.92E−87.842Translational elongationgi\|311248936Phenylalanyl-tRNA synthetase alpha chain**0.500.35**0.91**1.38**2.14E−84.332tRNA aminoacylation for protein translationgi\|345441771Aldolase C, fructose-bisphosphate**0.61**1.05**1.43**1.061.64E−78.242Fructose metabolic processgi\|213958609Glutamine:fructose-6-phosphate amidotransferase 1 variant 2**0.344.13**1.07**5.11**7.15E−116.583Controls the flux of glucose into the hexosamine pathwaygi\|281500757Porcine Aldehyde Reductase In Ternary Complex With Inhibitor**0.300.74**1.11**1.58**2.37E−811.693Alcohol dehydrogenase activity, zinc-dependentgi\|335284299T-complex protein 1 subunit zeta1.050.98**0.711.56**1.31E−712.625ATP bindinggi\|311247012Epidermal growth factor receptor kinase substrate 81.14**0.251.28**0.894.81E−85.474Rac protein signal transductiongi\|6039481340S ribosomal protein S161.181.15**0.654.61**1.87E−1013.012rRNA processinggi\|346227222Ribosomal protein L13a isoform 10.82**0.521.96**0.921.34E−810.782Translationgi\|346421378Serpin H10.95**0.59**0.99**2.29**6.74E−95.252Binds specifically to collagengi\|342349319Calnexin**0.14**0.90**2.331.50**2.81E−95.403Calcium ion bindinggi\|346644805Pinin**0.631.571.33**1.148.19E−81.232Transcription regulationgi\|8568188960S ribosomal protein L100.861.20**0.601.89**2.13E−86.083Structural constituent of ribosomegi\|311252000Fumarylacetoacetate hydrolase domain-containing protein 21.160.99**0.522.83**2.02E−93.512Hydrolase activitygi\|54020966Annexin A2**0.74**1.111.11**2.61**4.38E−937.7620Calcium-regulated membrane-binding proteingi\|350585373Myosin-14**0.72**0.77**2.25**0.766.57E−910.178ATP bindinggi\|51870491CDC37 cell division cycle 37 protein**0.74**1.12**1.37**1.064.61E−717.114Cell divisiongi\|85792232Eukaryotic translation initiation factor 4A isoform 1**0.721.791.26**0.894.13E−819.468Cytokine-mediated signaling pathwaygi\|4033507Annexin A4**0.711.451.54**1.091.01E−733.5411Calcium/phospholipid-binding proteingi\|343403779Ribosomal protein L131.24**0.70**1.18**1.50**1.68E−77.112Translational elongationgi\|4526896740S ribosomal protein S281.17**0.741.51**0.771.16E−726.254Translational elongationgi\|343432604Ubiquitin-conjugating enzyme E2 variant 2**0.711.981.291.38**2.85E−821.382Error-free post-replication DNA repair**Cluster 5: up-down-up regulation (6)**gi\|350588024Heterogeneous nuclear ribonucleoprotein D01.09**1.370.741.27**3.53E−716.424RNA catabolic processgi\|350586335Nuclease-sensitive element-binding protein 1**1.270.77**0.95**2.17**1.39E−820.956Mediates pre-mRNA alternative splicing regulationgi\|350585579Alpha-enolase**1.390.612.15**1.181.26E−818.2113Magnesium ion bindinggi\|8554209260S ribosomal protein L6**1.600.591.432.21**1.04E−89.513Translationgi\|194037373Coatomer subunit zeta-1 isoform 1**3.100.593.56**1.114.58E−1018.642Intracellular protein transportgi\|350594189Cadherin-10**1.601.380.631.46**5.83E−83.162Calcium ion binding**Cluster 6:down-up-down regulation (11)**gi\|342672022exportin-2**0.740.641.320.47**1.12E-73.604cell proliferationgi\|350583346ubiquitin associated protein 2-like isoform 3**0.57**0.94**3.310.56**3.86E-103.042binding of sperm to zona pellucidagi\|335309813coactosin-like protein0.96**0.681.260.26**6.36E-812.502Binds to F-actin in a calcium-independent mannergi\|350578507asparaginyl-tRNA synthetase0.94**0.411.630.73**2.92E-86.804tRNA aminoacylation for protein translationgi\|350596594malate dehydrogenase**0.560.571.280.53**1.18E-720.767L-malate dehydrogenase activitygi\|60389430m7GpppX diphosphatase**0.561.43**0.82**0.65**8.83E-810.092cellular response to menadionegi\|350529411proteasome (prosome, macropain) 26S subunit, ATPase, 2**0.512.732.910.61**7.12E-1013.635enzyme regulator activitygi\|51317314Histone H4**0.071.940.28**1.193.75E-950.497Core component of nucleosomegi\|19404462614-3-3 protein beta/alpha isoform 11.04**0.691.540.65**7.19E-832.528Ras protein signal transductiongi\|350578528peptidyl-prolyl cis-trans isomerase B**0.720.621.340.29**5.62E-823.205PPIases accelerate the folding of proteinsgi\|335282599interleukin enhancer-binding factor 3**0.300.702.830.58**1.13E-911.956Transcription regulation**Cluster 7:up-down-up-down regulation (1)**gi\|33529036545 kDa calcium-binding protein**1.390.591.450.48**2.99E-84.482calcium ion binding**Cluster 8: down-up-down-up regulation (1)**gi\|350594669ribosome-binding protein 1**0.691.640.631.92**1.11E-84.255rRNA processingThe 196 unique proteins identified with 95% confidence (corresponding to a protein score cutoff \>1.3), were clustered based on similar trends of differential 489 expression over times. % Cov (95) means percent coverage (95%). The proteins were considered to show a significant upward or downward trend if their expression 490 ratios relative to the mock control group at the same time post infection were \>1.25 or \<0.75, respectively. One-way analysis of variance (ANOVA) and LSD analysis 491 (SPSS 18.0) were used in this statistical test. Differences between groups through the time course were considered statistically significant for P values \< 0.05

Functional classification of identified proteins {#Sec14}
------------------------------------------------

Functional annotation of the 196 proteins that were significantly altered after infection of PK-15 cells with PCV2 was initially performed using Protein Center software. Three main annotation types were obtained from the gene ontology consortium Web site: Biological Processes, Subcellular Location, and Molecular Function. Enrichment analysis of biological processes showed that PCV2 infection primarily affects the generation of precursor metabolites and energy (Fig. [4](#Fig4){ref-type="fig"}a) and revealed nucleotide-binding, cytoskeletal protein binding, and hydrolyase activity as the commonly affected metabolic functions in PCV2-infected PK-15 cells (Fig. [4](#Fig4){ref-type="fig"}c). Furthermore, cellular component-based enrichment analysis showed that proteins with significant alterations are differentially distributed in cells (Fig. [4](#Fig4){ref-type="fig"}b).Fig. 4Classification of identified proteins based on functional annotations using Gene Ontology. **a** GO Biological processes. **b** GO Subcellular Location. **c** GO Molecular Function. *P* values were calculated using the MetaCore Tool in the GeneGO package (<http://www.genego.com/>)

Protein--protein interactions {#Sec15}
-----------------------------

Interactions between the virus and host cell are complex and mutual when a virus invades the host. Next, we aimed to determine how PCV2 interacts with PK-15 cell proteins and the effects of these interactions on cell function. The STRING database was searched for interactions with significantly altered proteins in response to PCV2 infection (Fig. [5](#Fig5){ref-type="fig"}). The analysis revealed several proteins with interesting interactions, including Hspa12a-Hyou1-Hspa5-Hspd1-Rsp16-Rsp18-Rpl5 and Canx-Calx-Ppib-Ppl10-Prdx2-Anxa2-Anxa1-Vim. These seed proteins play important functions in signal transduction and cell adhesion. For example, Anxa2 is a RNA-binding protein implicated in several cellular transport processes, including internalization and transport of cholesteryl esters, biogenesis of multivesicular bodies, recycling of plasma membrane receptors, and Ca^2+^-induced exocytosis of specific secretory granules \[[@CR24]\].Fig. 5Protein--protein interaction network analyzed via STRING software. An edge was drawn with up to seven different colored lines representing the existence of seven lines of evidence used in predicting associations. A *red line* indicates the presence of fusion evidence, a *green line* indicates neighborhood evidence, a *blue* *line* indicates co-occurrence evidence, a *purple line* indicates experimental evidence, a *yellow line* indicates text mining evidence, a *light blue line* indicates database evidence, and a *black line* indicates co-expression evidence (Color figure online)

Validation of changes in protein levels via Western blot {#Sec16}
--------------------------------------------------------

To validate the differentially expressed proteins identified using the iTRAQ labeled LC--MS/MS system, vimentin, Annexin I, Hsp90, and Rab-11A were selected for Western blot analysis. Equal amounts of cell lysate protein from PCV2-infected PK-15 and virus-free cells were tested with antibodies against vimentin, AnnexinI, Hsp90, and Rab-11A, respectively. As shown in Fig. [6](#Fig6){ref-type="fig"}, the Hsp90 was up-regulated at 96 hpi. In addition, the expression of vimentin, AnnexinI, and Rab-11A showed down-regulation in the prophase of infection, and then, they up-regulated later. The ratios of the four representative proteins between infected and uninfected cells were consistent with those obtained from iTRAQ-coupled 2D LC--MS/MS analysis. Protein spot levels were determined using ImageJ quantification software.Fig. 6Confirmation of four differentially expressed proteins (vimentin, Annexin I, Rab11A, and Hsp90) and viral Cap protein in PCV2-infected PK-15 cells using Western blot analysis (**a**). The levels of relative proteins were quantified with immunoblot scanning and normalized to the amount of β-actin (**b**)

Discussion and conclusions {#Sec17}
==========================

Upon virus infection, cellular environments are modified to eliminate the invading virus by host antiviral responses or to favor virus replication by viral evasion strategies. The changes of host gene production in virus-infected cells have been largely studied to elucidate pathogenic mechanism associated with such alterations. However, very limited information is currently available for cellular protein productions regulated after exposed to individual viral components. To further elucidate the molecular mechanisms involved in PCV2 infection of host cells, we screened the differentially expressed proteins associated with PK-15 cells infected with the virus using comparative proteomics. Several earlier studies have analyzed the interplay between PCV2 and host cells using proteomics analysis, which includes interactions of PCV2 and PK-15 cells \[[@CR15], [@CR16]\], porcine alveolar macrophages (PAMs) \[[@CR17], [@CR18]\], and inguinal lymph nodes of piglets inoculated with PCV2 \[[@CR14]\]. In order to determine further virus--host interactions and the processes leading to disease onset, a high-throughput quantitative proteomic approach, iTRAQ was utilized to investigate the differential proteomes of a highly permissive PK-15 clone cells in response to PCV2 infection. The results indicated that a total of 196 proteins displayed significantly altered expression at different time points post-infection. Four of these proteins were confirmed to be regulated in PCV2-infected PK-15 cells using immunoblotting as an independent analytical method. It provided critical clues for further analysis of PCV2 pathogenesis.

Proteomics is a novel methodology employed to detect the components of cellular protein interactions as well as host cellular pathophysiological processes that occur during virus infection \[[@CR25], [@CR26]\]. iTRAQ, combined with LC and tandem MS analysis, is emerging as a powerful technology in the search for disease-specific targets. This procedure is ideally suited to our study, since it allows the comparison of four time points after infection and four corresponding controls. Compared with mock infection, PCV2 did not induce visible cytopathic effects. Furthermore, the full cell monolayer appeared in PCV2-infected cells. Both IFA and Western blot results disclosed that PCV2 replicates in PK-15 cells. Differentially expressed proteins are involved in cytoskeleton organization, macromolecular biosynthesis, signal transduction, stress response, ubiquitin--proteasome pathway (UPP), and metabolic enzymes (Table [1](#Tab1){ref-type="table"}). Our data aid in the understanding of the pathogenesis of PCV2 infection. In our previous quantitative proteomics study, we identified that Hsp70 was up-regulated in PCV2-infected PAMs \[[@CR18]\]. Then, we firstly found that Hsp70 could positively regulate PCV2 replication in a continuous porcine monocytic cell line 3D4/31 \[[@CR27]\]. It can be seen that the results of proteomics study should be useful to elucidate the mechanism of replication of PCV2 in the future.

The host cytoskeletal network participates in the transport of viral components in the cell, particularly during the stages of the entry and exit of the virus \[[@CR28]\]. Our data strongly indicate an important role for cytoskeletal proteins in PCV2 infection in PK-15 cells. The identified microfilament-associated and microtubule-associated proteins, i.e., annexin A2 and beta 5-tubulin, were up-regulated (Table [1](#Tab1){ref-type="table"}), whereas the microtubule-associated protein 4, alpha-actin, and keratin 8 were down-regulated in the process of infection (Table [1](#Tab1){ref-type="table"}). The existing evidence suggests that actin can regulate gene transcription in virus-induced signaling. The mRNA-binding activity of actin is important for the anchoring, transporting, and topological positioning of mRNAs \[[@CR29]\]. With regard to β-tubulin, there are several reports showing that viruses may require microtubule components for RNA synthesis \[[@CR30]\]. α-tubulin was identified as being overexpressed when it interacts with Rep of PCV2 through colocalization and coimmunoprecipitation analyses \[[@CR15]\]. Changes in β-tubulin and vimentin levels have been detected in SARS-CoV22 and infectious bursal disease virus (IBDV) \[[@CR26], [@CR31]\]. However, Fan et al. \[[@CR16].\] indicated that β-tubulin level was down-regulated in infected PK-15 cells and speculated that the vimentin and β-tubulin networks collapse and disperse in host cells, leading to an unstable cytoskeletal structure and release of viral particles from the infected cells. The roles of these cytoskeletal proteins in PK15 cells after PCV2 infection should be further investigated.

Heat shock proteins (HSPs) are a class of multifunctional proteins that maintain cell stability when cells are exposed to elevated temperatures, pathogens, and/or other environmental stresses \[[@CR32]\]. Activation of the heat shock response might be a specific virus function that ensures proper synthesis of viral proteins and virions; thus, stress proteins may be important for virus replication \[[@CR33]\]. Mammalian cells have developed response networks which detect and control diverse forms of stress. One of these responses, known as heat shock response, is a universal mechanism necessary for cell survival under a variety of unfavorable conditions like virus infections \[[@CR34]\]. In the present study, the up-regulation of Hsp90, Hsp70, and Hsp60 was identified in the PCV2-infected PK-15 cells (Table [1](#Tab1){ref-type="table"}). Hsp60 is a mitochondrial chaperonin that is typically responsible for the transportation and refolding of proteins from the cytoplasm into the mitochondrial matrix, and it was reported that Hsp60 folds 30 % of the cytoplasmic proteins under heat stress \[[@CR35]\]. One study reported that Hsp60 can directly activate leukocytes, epithelial cells, and fibroblasts to secrete proinflammatory cytokines such as TNF and interleukins, which participate in the process of T cell-mediated immunity \[[@CR36]\]. It has been reported that HSPs inhibit the replication of IV and a variety of RNA viruses \[[@CR37]\]. Inhibition of the expression of Hsc70 blocks the nuclear export of the IV M1 and NP proteins and thereby inhibits the production of the progeny virus \[[@CR37]\]. Previously, we demonstrated that Hsp70 has a positive regulatory effect on PCV2 infection cycle, based on proteomics results on PCV2-infected PAMs \[[@CR27]\]. Hsp90 has a very important function in the folding of cell regulatory proteins and the refolding of stress-denatured polypeptides \[[@CR38]--[@CR40]\]. Prior research has also shown that Hsp90 is involved in the assembly and nuclear export process of IV RNPs \[[@CR41]\]. A previous report showed that an initial increase in Hsp90 expression at 12 h after infection suggests a cellular response to hMPV-induced ER stress initiated by an increase in unfolded or misfolded proteins \[[@CR42]\]. Recently, an association between Hsp90 protein complex and lamin A/C has been observed after oxidative stress \[[@CR43]\]. Also, in our PCV2-infected PK-15 cells, we observe an increase in Hsp90 and lamin subunit beta. Here, the increased information should be helpful to study on the molecular mechanisms underlying host--PCV2 interactions.

Several signal transduction-associated proteins were identified to be differentially expressed in the PCV2-infected cells. The 14-3-3 protein family is known to be involved in the regulation of several signal transduction pathways including those regulating the cell cycle, apoptosis, cytoskeletal remodeling, transcription, and stress responses \[[@CR44]\]. A prior study reported that the 14-3-3 protein interacts with the HCV core protein to activate kinase Raf-1 \[[@CR45]\], and the identified interaction of the 14-3-3 protein with Vpr has a functional significance for cell cycle regulation in HIV-1 infection \[[@CR46]\]. In our study, the expression of 14-3-3 protein in PCV2-infected PK-15 cells was down-regulated. This occurrence may be due to the cellular physiology dysfunction of PK-15 cells. Further work is clearly necessary to examine the function of 14-3-3 protein in PCV2-infected tissues.

Ubiquitin--proteasome pathway (UPP), a major intracellular protein degradation pathway, has recently been implicated in viral infections, including avoidance of host immune surveillance, viral maturation, viral progeny release, efficient viral replication, and reactivation of virus from latency \[[@CR47]\]. Some viruses have been reported to evolve different strategies to utilize the UPP for beneficial reasons, including the indication that ubiquitin--proteasome system is required for avoidance of host immune surveillance during HIV-1 and is necessary for transcriptional regulation of the DNA virus, herpes simplex virus (HSV) \[[@CR48], [@CR49]\]. Mumps virus and simian virus inhibit JAK/STAT signaling pathway through proteasome degradation of the cellular STAT protein to escape the interferon-initiated antiviral responses \[[@CR50]\]. In this study, PCV2 infection induced expression of the ubiquitin-conjugating enzyme E2, proteasome 26S subunit, and ubiquitin-associated protein 2. Therefore, their change in abundance levels may indicate to an important pathway affected by PCV2 replication. Whether PCV2 takes the similar or different strategy during infection has not been elucidated and deserves further investigation.

In summary, in this study, an iTRAQ proteomics approach was adopted to probe differentially expressed proteins in PCV2-infected PK-15 cells. Using unambiguous methods, we identified 196 cellular proteins that were significantly altered following PCV2 infection. The abundance of differentially expressed proteins should aid in elucidating molecular mechanisms associated with interactions between PCV2 and target cells. However, the proteomics results were preliminary data, which needed to be further elaborated and analyzed for understanding the roles of these proteins in PCV2 infection.
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